Check up: The COVID-crisis strikes leaving just 9 stocks in the black
Health & Biotech
Here’s our fortnightly wrap of all the news driving ASX health stocks.
Of the ASX’s 137-odd small cap health stocks, only nine were in positive territory over the last fortnight; nine were flat and 119 saw their share prices fall.
Code | Name | Price $ (March 18) | 2 week return % | 1 year return % | Market cap |
---|---|---|---|---|---|
TDL | TBG DIAGNOSTICS LTD | 0.27 | 938 | 575 | $17.9M |
SKN | SKIN ELEMENTS LTD | 0.022 | 83 | -33 | $5.8M |
NSB | NEUROSCIENTIFIC BIOPHARMACEU | 0.18 | 29 | 0 | $11.4M |
FTT | FACTOR THERAPEUTICS LTD | 0.003 | 20 | 0 | $2.1M |
MDR | MEDADVISOR LTD | 0.45 | 17 | 61 | $110.7M |
VBS | VECTUS BIOSYSTEMS LTD | 0.58 | 16 | 31 | $13.8M |
GLH | GLOBAL HEALTH LTD | 0.14 | 8 | -7 | $5.7M |
CTE | CRYOSITE LTD | 0.073 | 7 | 105 | $3.4M |
BOT | BOTANIX PHARMACEUTICALS LTD | 0.077 | 1 | -28 | $77.8M |
RGS | REGENEUS LTD | 0.07 | 0 | -30 | $19.5M |
VLS | VITA LIFE SCIENCES LTD | 0.65 | 0 | -25 | $35.5M |
NXS | NEXT SCIENCE LTD | 2.22 | 0 | 58 | $284.8M |
CP1 | CANNPAL ANIMAL THERAPEUTICS | 0.125 | 0 | -5 | $9.8M |
BPH | BPH ENERGY LTD | 0.001 | 0 | 0 | $3.3M |
RSH | RESPIRI LTD | 0.074 | 0 | -13 | $41.2M |
UBI | UNIVERSAL BIOSENSORS INC-CDI | 0.15 | 0 | -25 | $25.8M |
SIL | SMILES INCLUSIVE LTD | 0.035 | 0 | -75 | $5.1M |
ALT | ANALYTICA LTD | 0.002 | 0 | -50 | $7.0M |
NVL | NATIONAL VETERINARY CARE LTD | 3.59 | -2 | 95 | $241.4M |
CGS | COGSTATE LTD | 0.35 | -5 | 40 | $59.5M |
S66 | STAR COMBO PHARMA LTD | 0.48 | -6 | -22 | $41.1M |
PBP | PROBIOTEC LTD | 1.94 | -6 | 30 | $145.4M |
PAB | PATRYS LTD | 0.014 | -6 | -30 | $15.0M |
LBT | LBT INNOVATIONS LTD | 0.115 | -6 | 92 | $25.9M |
GSS | GENETIC SIGNATURES LTD | 1.03 | -8 | -17 | $146.8M |
ATH | ALTERITY THERAPEUTICS LTD | 0.012 | -8 | -76 | $10.7M |
LSH | LIFESPOT HEALTH LTD | 0.03 | -9 | -50 | $2.6M |
DXB | DIMERIX LTD | 0.14 | -10 | 55 | $25.4M |
ONT | 1300 SMILES LTD | 5.5 | -10 | -8 | $130.2M |
SVA | SIMAVITA LTD-CDI | 0.018 | -10 | -10 | $14.0M |
RAC | RACE ONCOLOGY LTD | 0.295 | -10 | 269 | $30.6M |
SDX | SIENNA CANCER DIAGNOSTICS LT | 0.027 | -10 | -55 | $10.7M |
RCE | RECCE PHARMACEUTICALS LTD | 0.34 | -10 | 100 | $45.4M |
KZA | KAZIA THERAPEUTICS LTD | 0.54 | -11 | 7 | $39.3M |
CYP | CYNATA THERAPEUTICS LTD | 0.79 | -12 | -55 | $81.4M |
ANR | ANATARA LIFESCIENCES LTD | 0.18 | -12 | -65 | $9.0M |
FFC | FARMAFORCE LTD | 0.06 | -12 | -33 | $7.7M |
PYC | PYC THERAPEUTICS LTD | 0.052 | -13 | 160 | $152.4M |
NC6 | NANOLLOSE LTD | 0.04 | -13 | -43 | $3.0M |
ADR | ADHERIUM LTD | 0.02 | -13 | -33 | $9.9M |
EHH | EAGLE HEALTH HOLDINGS LTD | 0.16 | -14 | -38 | $55.3M |
PIQ | PROTEOMICS INTERNATIONAL LAB | 0.25 | -15 | -31 | $23.0M |
MDC | MEDLAB CLINICAL LTD | 0.21 | -16 | -46 | $49.0M |
ADO | ANTEOTECH LTD | 0.015 | -16 | -25 | $22.5M |
PAL | PALLA PHARMA LTD | 0.68 | -17 | -46 | $85.0M |
BXN | BIOXYNE LTD | 0.01 | -17 | -50 | $6.4M |
IMM | IMMUTEP LTD | 0.32 | -18 | -11 | $132.4M |
LCT | LIVING CELL TECHNOLOGIES LTD | 0.014 | -18 | -65 | $8.0M |
AHX | APIAM ANIMAL HEALTH LTD | 0.39 | -18 | -17 | $45.2M |
BNO | BIONOMICS LTD | 0.041 | -18 | -77 | $20.7M |
BD1 | BARD1 LIFE SCIENCES LTD | 0.023 | -18 | 15 | $31.5M |
DVL | DORSAVI LTD | 0.017 | -19 | -60 | $3.9M |
OSL | ONCOSIL MEDICAL LTD | 0.11 | -19 | -35 | $58.0M |
VHT | VOLPARA HEALTH TECHNOLOGIES | 1.15 | -20 | -7 | $251.3M |
ALC | ALCIDION GROUP LTD | 0.12 | -20 | 140 | $118.9M |
SUD | SUDA PHARMACEUTICALS LTD | 0.046 | -21 | -54 | $6.5M |
BIT | BIOTRON LTD | 0.097 | -22 | 7 | $68.1M |
1AD | ADALTA LTD | 0.06 | -22 | -76 | $10.2M |
CDX | CARDIEX LTD | 0.018 | -22 | -55 | $13.6M |
IVX | INVION LTD | 0.007 | -22 | -50 | $38.5M |
PAA | PHARMAUST LTD | 0.07 | -22 | 75 | $21.1M |
CYC | CYCLOPHARM LTD | 0.8 | -23 | -29 | $62.6M |
SCU | STEMCELL UNITED LTD | 0.01 | -23 | -50 | $6.4M |
CAJ | CAPITOL HEALTH LTD | 0.22 | -24 | 7 | $174.4M |
HLA | HEALTHIA LTD | 0.91 | -24 | -10 | $57.4M |
MMJ | MMJ GROUP HOLDINGS LTD | 0.076 | -24 | -65 | $17.1M |
ACR | ACRUX LTD | 0.11 | -24 | -39 | $18.5M |
ELX | ELLEX MEDICAL LASERS LTD | 0.51 | -24 | -22 | $83.3M |
AVE | AVECHO BIOTECHNOLOGY LTD | 0.003 | -25 | -25 | $4.7M |
SDI | SDI LTD | 0.7 | -25 | -11 | $83.8M |
VTI | VISIONEERING TECH-CDI | 0.025 | -26 | -71 | $10.9M |
AZV | AZURE HEALTHCARE LTD | 0.07 | -26 | 40 | $19.9M |
IHL | IMPRESSION HEALTHCARE LTD | 0.037 | -26 | 85 | $26.5M |
AC8 | AUSCANN GROUP HOLDINGS LTD | 0.17 | -26 | -50 | $53.9M |
OCC | ORTHOCELL LTD | 0.25 | -26 | 75 | $46.2M |
TD1 | TALI DIGITAL LTD | 0.017 | -26 | -26 | $12.7M |
OSX | OSTEOPORE LTD | 0.365 | -27 | 83 | $35.4M |
NOX | NOXOPHARM LTD | 0.165 | -27 | -63 | $25.9M |
ZLD | ZELIRA THERAPEUTICS LTD | 0.032 | -27 | -36 | $30.9M |
CAN | CANN GROUP LTD | 0.67 | -28 | -60 | $96.9M |
NTI | NEUROTECH INTERNATIONAL LTD | 0.005 | -29 | -67 | $699K |
MVF | MONASH IVF GROUP LTD | 0.65 | -29 | -41 | $153.3M |
MEB | MEDIBIO LTD | 0.005 | -29 | -70 | $5.0M |
TLX | TELIX PHARMACEUTICALS LTD | 0.955 | -29 | 0 | $250.9M |
ICS | ICSGLOBAL LTD | 1.7 | -30 | 166 | $17.9M |
UCM | USCOM LTD | 0.26 | -30 | 63 | $37.4M |
PXS | PHARMAXIS LTD | 0.067 | -30 | -73 | $26.4M |
GMV | G MEDICAL INNOVATION HOLDING | 0.05 | -30 | -81 | $19.4M |
IMU | IMUGENE LTD | 0.018 | -30 | -10 | $79.7M |
BLT | BENITEC BIOPHARMA LTD | 0.024 | -31 | -83 | $7.7M |
IMC | IMMURON LTD | 0.086 | -31 | -63 | $15.2M |
M7T | MACH7 TECHNOLOGIES LTD | 0.47 | -31 | 182 | $95.1M |
RHT | RESONANCE HEALTH LTD | 0.1 | -31 | 31 | $45.3M |
RHY | RHYTHM BIOSCIENCES LTD | 0.05 | -32 | -71 | $5.8M |
ANP | ANTISENSE THERAPEUTICS LTD | 0.042 | -32 | 5 | $20.0M |
ZNO | ZOONO GROUP LTD | 1.49 | -33 | 1142 | $243.3M |
OSP | OSPREY MEDICAL INC-CDI | 0.012 | -33 | -90 | $5.2M |
IDT | IDT AUSTRALIA LTD | 0.09 | -33 | -36 | $21.3M |
MXC | MGC PHARMACEUTICALS LTD | 0.018 | -33 | -55 | $25.2M |
RNO | RHINOMED LTD | 0.1 | -33 | -47 | $16.9M |
PCK | PAINCHEK LTD | 0.075 | -33 | 88 | $72.5M |
SOM | SOMNOMED LTD | 2 | -33 | 8 | $125.6M |
NYR | NYRADA INC-CDI | 0.12 | -33 | -50 | $13.3M |
CDY | CELLMID LTD | 0.1 | -33 | -60 | $9.7M |
IBX | IMAGION BIOSYSTEMS LTD | 0.016 | -33 | -46 | $8.7M |
PGC | PARAGON CARE LTD | 0.15 | -33 | -66 | $50.7M |
1ST | 1ST GROUP LTD | 0.026 | -33 | -60 | $11.0M |
ACW | ACTINOGEN MEDICAL LTD | 0.017 | -34 | -70 | $17.9M |
ATX | AMPLIA THERAPEUTICS LTD | 0.05 | -35 | -62 | $3.3M |
MEM | MEMPHASYS LTD | 0.038 | -36 | 90 | $28.7M |
IPD | IMPEDIMED LTD | 0.056 | -36 | -75 | $33.7M |
CPH | CRESO PHARMA LTD | 0.056 | -36 | -84 | $11.6M |
THC | THC GLOBAL GROUP LTD | 0.22 | -37 | -60 | $31.0M |
PSQ | PACIFIC SMILES GROUP LTD | 1.11 | -37 | -7 | $168.7M |
ESE | ESENSE-LAB LTD-CDI | 0.005 | -38 | -74 | $948K |
OIL | OPTISCAN IMAGING LTD | 0.015 | -38 | -70 | $7.2M |
AGH | ALTHEA GROUP HOLDINGS LTD | 0.19 | -39 | -48 | $43.2M |
NEU | NEUREN PHARMACEUTICALS LTD | 1.17 | -39 | 0 | $120.7M |
APH | AUSTRALIAN PRIMARY HEMP LTD | 0.08 | -40 | -50 | $5.6M |
CMP | COMPUMEDICS LTD | 0.4 | -40 | 14 | $70.9M |
AVH | AVITA MEDICAL LTD | 0.35 | -41 | 100 | $750.6M |
PNV | POLYNOVO LTD | 1.45 | -42 | 100 | $998.2M |
AMT | ALLEGRA ORTHOPAEDICS LTD | 0.15 | -42 | 25 | $14.9M |
OVN | OVENTUS MEDICAL LTD | 0.3 | -44 | 4 | $39.2M |
OPT | OPTHEA LTD | 1.8 | -45 | 128 | $484.5M |
MVP | MEDICAL DEVELOPMENTS INTERNA | 4.78 | -46 | 9 | $324.1M |
JHC | JAPARA HEALTHCARE LTD | 0.49 | -47 | -66 | $133.6M |
HCT | HOLISTA COLLTECH LTD | 0.09 | -47 | 9 | $24.2M |
EXL | ELIXINOL GLOBAL LTD | 0.24 | -49 | -92 | $32.4M |
GTG | GENETIC TECHNOLOGIES LTD | 0.004 | -50 | -75 | $16.3M |
RAP | RESAPP HEALTH LTD | 0.081 | -56 | -11 | $58.8M |
ONE | ONEVIEW HEALTHCARE PLC-CDI | 0.05 | -57 | -87 | $8.8M |
PAR | PARADIGM BIOPHARMACEUTICALS | 1.26 | -58 | -17 | $249.3M |
JHL | JAYEX HEALTHCARE LTD | 0.013 | -68 | -66 | $2.3M |
PTX | PRESCIENT THERAPEUTICS LTD | 0.029 | -69 | -55 | $10.7M |
BWX | BWX LTD | 2.8 | -73 | 20 | $345.4M |
MX1 | MICRO-X LTD | 0.14 | -84 | -44 | $36.3M |
Interestingly, all but one of the companies that have survived the market rout were not selling hand sanitiser.
TBG Diagnostics (ASX:TDL) got a COVID-19 testing kit approved for sale in Europe — although the news was out before it could go into a trading halt on Tuesday.
Testing kits are in short supply around the world.
Skin Elements (ASX:SKN) surged in the polls over the last fortnight after quietly dropping news of a new product in its half-year report. You guessed it, it’s hand sanitiser.
The only issue, for the punters who quickly jumped on the stock hoping for another Zoono (ASX:ZNO) (a company that went from $14m last year to $250m and is doing $150,000 in sales online a day now), is that there is no information available about Invisi Shield, when it’s going to be ready for sale, or where.
The only information that has been released is online in the half-year report confirming a development program and that it had been brought forward for “immediate release”.
The ASX pinged Skin Elements for its stock surge and the company promised to give investors a little more to go on. It is yet to do so.
Neuroscientific Biopharmaceuticals (ASX:NSB) proved that good results can trump a crisis.
A preclinical study into its lead drug candidate, EmtinB, for Multiple Sclerosis had a significant positive effect on the proliferation of cells that delay damage to the protective sheath over nerves.
MS causes damage to the protective sheath, myelin, that covers nerve fibers, disrupting communication between the brain and the rest of the body. EmtinB helped to grow more of the support cells of the central nervous system called oligodendrocytes, which create the myelin sheath that surrounds the nerve fibers.
The study indicated a very significant effect on remyelination and increased the total number of cells by up to five times after five days.
READ: Dementia sufferers in Australia will hit 1 million, can these small caps come up with a treatment?
Factor Therapeutics (ASX:FTT), the company that collapsed after phase two trials into a wound care product failed in 2018, was a surprise market beater.
Investors have been getting antsy over the long 18-month wait but the board has not rushed into anything.
It has been carefully sifting through new opportunities for the company to buy and says it’s “on the final stretch of due diligence” for three, with one in particular close to a final deal.
Blood banker Cryosite (ASX:CTE) was in the black because former star stockbroker, and its former chairman, Andrew Kroger was buying up large amounts of stock.
The now-non executive director lifted his ownership from 38 per cent to 40 per cent.